Legal Marijuana Market Size to Worth USD 113.26 Bn by 2033

The global legal marijuana market size was USD 30.75 billion in 2023, grew to USD 33.74 billion in 2024 and is expected to be worth around USD 113.26 billion by 2033.

Ottawa, March 07, 2024 (GLOBE NEWSWIRE) — The global legal marijuana market is expected to expand at a double-digit CAGR of 14.4% from 2023 to 2033. North America has contributed more than 70% of the market share in 2023, a study published by Towards Healthcare a sister firm of Precedence Research.

Report Highlights:

  • The flower buds product type dominated the market in 2023 with a 51% share, proving their enduring popularity.
  • Medical marijuana for pain management topped the market in 2023, holding a 28% share, highlighting its therapeutic potential.

In 2021, the National Institute of Health estimates that 36 states allow medical marijuana, but the rules for getting it vary. Even though it’s legal in many places, medical marijuana is highly recommended for chronic pain management.

Marijuana is a plant that is commonly used for recreational and medicinal purposes. It contains a chemical called THC, which is responsible for the “high” feeling. People may smoke, vape, or eat marijuana for various effects, including relaxation and pain relief. However, it’s important to note that its legal status varies across different places. Legal marijuana refers to the regulated cultivation, sale, and use of cannabis within the boundaries of specific laws. It’s a significant shift in how society views and manages the use of marijuana. The legalization can be categorized into two main types: recreational and medicinal.

In places where recreational marijuana is legal, adults can use it for non-medicinal purposes. This often involves regulations on age restrictions, permissible quantities, and locations for consumption. Legalizing marijuana for medicinal purposes means that doctors can prescribe it to treat certain medical conditions. This recognizes marijuana’s potential therapeutic benefits.

Download a short version of this report @

Several U.S. States have Legalized Marijuana for Recreational and Medicinal Use

Recreational Use Medicinal Use
Colorado Arizona
Washington Arkansas
Alaska Connecticut
California Florida
Nevada Hawaii
Michigan Maryland
Massachusetts Minnesota
Illinois Missouri
Maine New Mexico
Montana North Dakota
New Jersey Pennsylvania
New York Rhode Island
Other 12 States Utah
  West Virginia
  Other 20 States

The Role of Marijuana in Medicinal Use

The medicinal use of marijuana has indeed contributed to the growth of the global legal marijuana market. The increasing acceptance of cannabis for medical purposes has led to the legalization of medical marijuana in numerous countries and states. This has created a burgeoning market for legal cannabis products, such as oils, tinctures, and capsules, customized to address various medical conditions.

One key factor driving this demand is the therapeutic potential of cannabinoids, the active compounds in marijuana. Cannabidiol (CBD), for instance, is renowned for its purported anti-inflammatory and analgesic properties, making it a popular choice for conditions like chronic pain and certain neurological disorders. As more research is conducted on the medical benefits of marijuana, there’s a growing understanding of its potential applications in treating conditions like epilepsy and anxiety and even in alleviating the side effects of chemotherapy.

The changing societal attitudes toward marijuana have paved the way for increased legalization, not only for medical but also for recreational use in some regions. This has created a more robust legal framework, fostering a legitimate and regulated market. As governments recognize the economic potential of the cannabis industry, they are more inclined to implement policies that support its growth. The medicinal use of marijuana has undeniably played a significant role in boosting the global demand for legal marijuana.

Legalization aims to balance individual freedom, public health and economic considerations. As with any substance, moderation and understanding the legal framework are critical to a positive and responsible experience.

You can place an order or ask any questions, please feel free to contact us at

Increasing Acceptance of Marijuana for Medical and Recreational Use

The growing acceptance of marijuana for both medical and recreational purposes can be attributed to shifting societal attitudes and an expanding understanding of its potential benefits. Regarding medical use, numerous studies suggest that cannabinoids, the compounds found in marijuana, possess therapeutic properties. These properties range from alleviating chronic pain and reducing chemotherapy-induced nausea to enhancing appetite in conditions such as HIV/AIDS. As awareness of these potential medical benefits increases, there is a noticeable trend towards recognizing marijuana as a valid and effective medical treatment.

On the recreational front, changing attitudes challenge traditional stigmas linked to marijuana use. Many now perceive it as a means to relax and unwind, comparable to consuming a glass of wine. As societies become more open-minded, the concept of responsible recreational marijuana use gains traction, further contributing to its acceptance. The economic impact of legalizing marijuana is a substantial driver in its growing acceptance. The legalization process creates new industries, generates tax revenue, and offers job opportunities. Governments, recognizing these financial advantages, are more inclined to support and promote the acceptance of marijuana.

Additionally, equally significant is the evolving public opinion surrounding marijuana. As individuals share positive experiences, whether related to medical or recreational use, stereotypes associated with marijuana are breaking down. This shift in perception plays a crucial role in fostering acceptance and broadening the understanding of marijuana’s role in society.

Marijuana is a Legitimate and Effective Option for Pain Management

The rising global demand for legal marijuana in pain management is fueled by a combination of factors that collectively drive the expansion of this market. First and foremost, the efficacy of marijuana, particularly cannabinoids like THC and CBD, in alleviating various types of pain, including chronic conditions, has positioned it as a compelling alternative to traditional pain medications. This effectiveness has led to a growing interest and demand among individuals seeking alternative pain relief solutions. A crucial contributor to the increasing demand is the shifting regulatory landscape globally. As more countries and regions legalize the medical use of marijuana, there is a broader acceptance of its role in pain management. This regulatory shift not only legitimizes the cultivation, distribution, and use of marijuana but also creates new opportunities for the growth of the legal marijuana market on a global scale.

For Instance,

  • According to the National Institute of Health, the study provides initial nationwide estimates on new and high-impact chronic pain (HICP). In 2020, the incidence of new chronic pain cases was notably high at 52.4 cases per 1,000 persons per year, surpassing rates for conditions like diabetes, depression, and hypertension. Early pain management is crucial, as 14.9% of those with non-chronic pain in 2019 developed chronic pain in 2020.
  • Chronic pain tends to persist, with 61.4% still experiencing it a year later. HICP developed at a rate of 190 cases/1,000 per year, and 361 cases/1,000 per year persisted after a year. Notably, 10.4% of individuals with chronic pain in 2019 were pain-free in 2020. Managing the increasing daily prevalence of chronic pain requires effective strategies, and some suggest marijuana as a potential option.
  • In 2021, according to the National Institute of Health, 36 states have legalized marijuana for medicinal purposes.
  • According to the Center for Disease Control and Prevention, chronic pain is a big problem in the U.S., affecting about 1 in 5 people, and it costs around $560 billion for medical care and disability.

Public awareness and education about the potential therapeutic benefits of marijuana for pain management are pivotal in driving its increased demand. Both patients and healthcare professionals are becoming more informed about the therapeutic properties of cannabinoids, fostering greater acceptance and growing demand for legal marijuana products designed for pain relief. Changing societal attitudes towards cannabis also plays a significant role in the surge of demand. With an increasing number of people viewing marijuana as a legitimate and effective option for pain relief, individuals are becoming more open to incorporating it into their pain management strategies, contributing to the overall uptick in demand. Additionally, the legal marijuana industry presents substantial economic opportunities. Governments, recognizing the potential for tax revenue and job creation, are incentivized to support and facilitate the legal cultivation and distribution of marijuana for medical purposes. This economic aspect further propels the global expansion of legal marijuana markets in the context of pain management.

Customize this study as per your requirement @

Ongoing research into the medicinal properties of cannabinoids is a driving force behind the innovation of marijuana-based products tailored specifically for pain management. This continuous evolution in product offerings adds to the sustained demand for legal marijuana in the global market. The increased international demand for legal marijuana in pain management is a multifaceted phenomenon driven by its perceived efficacy, changing regulations, heightened awareness, evolving societal attitudes, economic incentives, and ongoing research advancements. These interconnected factors collectively contribute to the growing acceptance and utilization of legal marijuana as a viable option in pain management on a global scale.

Regulatory Hurdles Slowdown the Progress of Marijuana Market

Regulatory hurdles act like speed bumps for the legal marijuana market. Imagine you’re driving on a road, and suddenly, there are many rules and restrictions. In the marijuana market, these rules come from the government. Different states have different rules about growing, selling, and using marijuana. It’s like having different traffic rules in each city you visit.

Additionally, even in states where it’s legal, there are often many specific regulations to follow. For example, businesses might need licenses, and there could be limits on how much marijuana they can grow or sell. Furthermore, here’s the tricky part: because marijuana is still illegal under federal law in some places, businesses face challenges with things like banking. Imagine not being able to use regular banks for your business transactions – that makes it challenging to manage money and grow the business smoothly. So, these regulatory hurdles are like a bunch of roadblocks that slow down the progress of the legal marijuana market, making it harder for companies to thrive.

Browse More Insights of Towards Healthcare:

  • The global cell therapy manufacturing market was valued at USD 3.92 billion in 2022 to reach around USD 16.40 billion by 2032, growing at 16% CAGR from 2023 and 2032.
  • The global asthma treatment market size to grow from USD 25 billion in 2022 to reach USD 36 billion by 2032, registered at a CAGR of 3.4% between 2023 and 2032.
  • The global blood pressure monitoring devices market is estimated to grow from USD 1.77 billion in 2022 to reach around USD 6.28 billion by 2032 at a 14.1% growth CAGR between 2023 and 2032.
  • The global cold storage market size was valued at USD 112 billion in 2022 to hit around USD 383.05 billion by 2032 expanding at a 12% CAGR from 2023 to 2032.
  • The global AI in genomics market size surpassed USD 397.64 million in 2022 to reach around USD 7,365.59 million by 2032 at an expanding 23.6% CAGR between 2023 and 2032.
  • The AI in cancer diagnostics market was valued at USD 892.23 million in 2022 to soar around USD 2,084.34 million by 2032, expanding at a 9.35% CAGR from 2023 to 2032.
  • The global smart healthcare market size to grow from USD 201.83 billion in 2022 to reach around USD 1,097.27 billion by 2032, at a staggering 18.5% CAGR between 2023 and 2032.
  • The global digital health market was estimated at USD 262.63 billion in 2022 to reach around USD 939.54 billion by 2032, expanding at a 13.1% of CAGR between 2023 and 2032.
  • The global health and wellness market is to grow from USD 5.24 trillion in 2022 to hit an estimated USD 8.94 trillion by 2032, at an expanding 5.46% CAGR between 2023 and 2032.
  • The global hospital services market was valued at USD 9.29 trillion in 2022, projected to reach USD 21.27 trillion by 2032, growing at a CAGR of 9.15% from 2023 to 2032.

Geographical Landscape

The geographical landscape for legal marijuana in North America is evolving, with various states and countries adopting different approaches. States like California, Oregon, and Washington were among the pioneers in legalizing recreational marijuana. They have established mature markets with a wide range of products and services. Mexico has taken steps toward legalizing recreational marijuana, which could significantly impact the overall North American market.

For Instance,

  • In the U.S., about 33 states support marijuana in some way, creating new jobs and economic opportunities in the legal marijuana industry. More states are expected to legalize cannabis, and federal lawmakers are considering changes, allowing more Americans to access it legally.

Germany has a legalized medical marijuana program, and it has become one of the largest medical cannabis markets in Europe. Patients with certain conditions can access medical cannabis through pharmacies. Switzerland allows low-THC cannabis products with less than 1% THC content, creating a unique market for products like CBD.

The Asia Pacific region generally has strict regulations on marijuana, with limited instances of legalization for medical purposes in some areas. Australia has legalized the use of medical cannabis at the federal level. However, regulations vary by state, and access can be challenging.

For Instance,

  • According to the National Library of Medicine, in Australia, marijuana is used for both medical and recreational purposes. About one-third of Australians aged 22 or older, around 5.8 million people, have tried marijuana, with approximately 1 million using it each year. An estimated 750,000 Australians use it weekly, and 300,000 use it daily. Australia has one of the highest marijuana use rates globally, especially among its native population.

Some states have also decriminalized small amounts of recreational use. In New Zealand, a 2020 referendum on recreational cannabis legalization did not pass. However, there is an existing medical cannabis program allowing for the use of medicinal marijuana under certain conditions.

Competitive Landscape

The legal marijuana market has a dynamic competitive landscape with various players operating across cultivation, distribution, and retail. Key factors include regulatory environments, product diversity, and brand positioning. Regional regulations significantly impact market dynamics, shaping the competitive strategies of industry participants. Ongoing developments, mergers, and partnerships contribute to the fluidity of the legal marijuana market’s competitive landscape. As the medical cannabis industry continues its global expansion, the competitive dynamics within the market are anticipated to experience additional transformation.

The rapidly changing scenario of the legal marijuana industry:

  • In January 2024, Canopy Growth Corporation introduced new products, like Tweed soft gels and oils with minor cannabinoids, larger Tweed, and exclusive medical pre-rolls.
  • In January 2024, Aurora Cannabis Inc. just released three new cannabis drinks, initially for veteran patients.

Market Players

  • Curaleaf Holdings Inc.
  • Green Thumb Industries Inc.
  • Canopy Growth Corporation
  • Aurora Cannabis Inc.
  • Maricann Inc.
  • Jazz Pharmaceuticals, Inc.
  • Organigram Holdings Inc.
  • Controlled Environments Limited
  • Lexaria Bioscience
  • Tikun Olam

Market Segment

By Product Type

  • Flower Buds
  • Oils
  • Tinctures
  • Others

By Application

  • Medical
    • Pain Management
    • Neurological Disorders
    • Mental Health
    • Gastrointestinal Disorders
    • Cancer Support
    • Others
  • Recreational

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Acquire our comprehensive analysis today @

You can place an order or ask any questions, please feel free to contact us at

Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.


Browse our Brand-New Journal@

Browse our Consulting Website@

For Latest Update Follow Us:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.